MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/ageing/afad172

Медицинская библиотека · Age and ageing · 2023

Call to action: a five nations consensus on the use of intravenous zoledronate after hip fracture.

Johansen Antony, Sahota Opinder, Dockery Frances, Black Alison J, MacLullich Alasdair M J, Javaid M Kassim, Ahern Emer, Gregson Celia L

Consensus StatementСтатьяПеревод в очереди

Аннотация

Currently in the UK and Ireland, after a hip fracture most patients do not receive bone protection medication to reduce the risk of refracture. Yet randomised controlled trial data specifically examining patients with hip fracture have shown that intravenous zoledronate reduces refracture risk by a third. Despite this evidence, use of intravenous zoledronate is highly variable following a hip fracture; many hospitals are providing this treatment, whilst most are currently not. A range of clinical uncertainties, doubts over the evidence base and practical concerns are cited as reasons. This paper discusses these concerns and provides guidance from expert consensus, aiming to assist orthogeriatricians, pharmacists and health services managers establish local protocols to deliver this highly clinically and cost-effective treatment to patients before they leave hospital, in order to reduce costly re-fractures in this frail population.

Для цитирования: Johansen Antony, Sahota Opinder, Dockery Frances, Black Alison J, MacLullich Alasdair M J, Javaid M Kassim, Ahern Emer, Gregson Celia L. Call to action: a five nations consensus on the use of intravenous zoledronate after hip fracture.. Age and ageing. 2023. DOI: 10.1093/ageing/afad172.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.